BLOC1S1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.746200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.105800E-01
Normal-vs-Stage2
6.825200E-01
Normal-vs-Stage3
9.524800E-01
Normal-vs-Stage4
5.748800E-01
Stage1-vs-Stage2
2.653800E-01
Stage1-vs-Stage3
2.726000E-01
Stage1-vs-Stage4
1.340150E-01
Stage2-vs-Stage3
5.799600E-01
Stage2-vs-Stage4
4.162200E-01
Stage3-vs-Stage4
8.441600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.854800E-01
Normal-vs-AfricanAmerican
7.411600E-01
Normal-vs-Asian
3.851200E-01
Caucasian-vs-AfricanAmerican
6.193200E-01
Caucasian-vs-Asian
6.169200E-01
AfricanAmerican-vs-Asian
3.722200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.309800E-01
Normal-vs-Female
6.550000E-01
Male-vs-Female
4.468800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.652600E-01
Normal-vs-Age(41-60Yrs)
5.819600E-01
Normal-vs-Age(61-80Yrs)
6.450600E-01
Normal-vs-Age(81-100Yrs)
2.802600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.888200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.725000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.152400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.340600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.517000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.135200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.613800E-01
Normal-vs-Daily Drinker
4.459600E-01
Normal-vs-Weekly Drinker
3.547200E-01
Normal-vs-Occasional Drinker
4.542800E-01
Normal-vs-Social Drinker
7.489400E-01
Non Drinker-vs-Daily Drinker
3.006200E-01
Non Drinker-vs-Weekly Drinker
9.727200E-01
Non Drinker-vs-Occasional Drinker
6.857600E-01
Non Drinker-vs-Social Drinker
7.542400E-01
Daily Drinker-vs-Weekly Drinker
2.881600E-01
Daily Drinker-vs-Occasional Drinker
5.337600E-01
Daily Drinker-vs-Social Drinker
2.667000E-01
Weekly Drinker-vs-Occasional Drinker
6.463400E-01
Weekly Drinker-vs-Social Drinker
6.858000E-01
Occasional Drinker-vs-Social Drinker
4.777200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.852800E-01
Normal-vs-Grade 2
2.205600E-01
Normal-vs-Grade 3
4.198200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.966100E-02
Grade 1-vs-Grade 3
2.201900E-02
Grade 1-vs-Grade 4
2.852800E-01
Grade 2-vs-Grade 3
3.100600E-01
Grade 2-vs-Grade 4
2.205600E-01
Grade 3-vs-Grade 4
4.198200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.008400E-01
Normal-vs-NonDiabetic
4.769000E-01
Diabetic-vs-NonDiabetic
1.970420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.872800E-01
Normal-vs-NoPancreatitis
5.716400E-01
Pancreatitis-vs-NoPancreatitis
5.242200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.681200E-01
Normal-vs-N1
7.103800E-01
N0-vs-N1
1.936430E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.232800E-01
Normal-vs-TP53-NonMutant
6.793600E-01
TP53-Mutant-vs-TP53-NonMutant
3.788400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
